USD 140.0 Billion
Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Strain(H5, H7), By Application(Chicken, Turkey) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2886 |
Region:
Global |
Published Date: May, 2024
Pages:
215
|
Tables:
63 |
Figures:
70
Avian Influenza Vaccine Market Insights
Global Avian Influenza Vaccine Market size was valued at USD 140.0 Billion in 2022 and is poised to grow from USD 145.88 Billion in 2023 to USD 202.74 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).
Avian influenza is caused by avian influenza virus type A, which is found in waterfowl and subsequently causes disease in domestic poultry. The virus was first detected in China. The Asian H5N1 version was discovered the following year in an outbreak in Hong Kong and has since spread to Europe, Asia, North and South America, Africa and the Middle East Avian influenza can be classified as a pandemic greater virus and less virulent based on its molecular structure. Depending on the virus, the viruses are classified into H5N1, H7N3, H7N7, H7N9, and H9N2. In addition, type A virus of subtype H5N1 is currently considered to be the most pathogenic avian influenza virus under investigation. Bird flu is known to be transmitted to humans through nose and mouth breathing. Classification of avian influenza vaccines includes H5 avian influenza vaccine, H7 avian influenza vaccine, and H9 avian influenza vaccine. Among manufacturers, China stands out as the largest supplier of avian influenza vaccine, with the US being the largest supplier.
There were 633,323 adults in the US. with cirrhosis, or about 0.27% of the population. Sixty-nine percent said they did not suspect liver disease. It was higher among non-Hispanic blacks, Mexican Americans who were poor and had less than 12th grade education. Diabetes mellitus, alcohol abuse, hepatitis C and B, male gender, older age, and cirrhosis were independently associated, with 53.5% accounting for the proportion of the population due to viral hepatitis (mostly hepatitis C), diabetes mellitus, and excessive alcohol consumption every two years in cirrhosis. There was a mortality rate of 26.4, compared with 8.4% in characteristic-matched controls.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
H5
Fastest Growth
H7
Growth Rate
4.2% CAGR
Global Avian Influenza Vaccine Market ($ Bn)
Country Share for Asia Pacific Region (%)
Global Avian Influenza Vaccine Market By Strain ($ Bn)
Global Avian Influenza Vaccine Market By Strain (%)
To get more reports on the above market click here to Buy The Report
Avian Influenza Vaccine Market Segmental Analysis
The avian influenza vaccine market has been segmented by strain and application. The market, based on strain, has been bifurcated into H5, H7, and H9. Based on application, the avian influenza vaccine market has been chicken, turkey, and goose & duck. The Avian Influenza Vaccine Market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.
Analysis by Strain
Avian influenza viruses are classified based on their hemagglutinin (H) and neuraminidase (N)-related proteins. The H5 subtype is associated with highly pathogenic avian influenza (HPAI) that can cause severe disease in poultry. The H5 subtype is generally associated with the emergence of highly pathogenic influenza strains, which can cause severe disease in poultry populations
Avian influenza vaccines targeting these specific subtypes are being developed to prevent the spread of the HPAI virus in poultry. Vaccination helps reduce the incidence of serious diseases in the poultry industry and reduces economic losses.
Vaccines targeting the H7 subtype are needed to prevent the spread of HPAIs in poultry populations. These vaccines are designed to boost the immune system and reduce the severity of the disease. The presence of the H7 subtype increases the risk of the virus becoming more virulent, this poses a threat to livestock and public health. Avian influenza vaccination for the H7 subtype plays an important role in risk prevention and active control. Timely vaccination of birds can prevent the evolution of pathogenic avian influenza (LPAI) into highly contagious forms.
Analysis by Application
Turkey is a major focus of the global avian influenza vaccine market as they are one of the most widely raised poultry species worldwide. The development and use of avian influenza vaccines for poultry is essential to protect the poultry industry and prevent economic losses due to pandemic outbreaks.
Like chickens, chicken is susceptible to bird flu virus. Vaccination is an important preventive measure to protect turkey populations. The global avian influenza vaccine market can differentiate between poultry and turkey vaccines to meet the specific needs of each animal species.
Global Avian Influenza Vaccine Market By Strain (%), 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Avian Influenza Vaccine Market Regional Insights
The global avian influenza vaccine market is dominated by Asia Pacific. This can be attributed to increased poultry production and increasing outbreaks of bird flu in the region. China produced 13,900 thousand metric tons of poultry meat in 2022, according to a recent Foreign Agricultural Service/USDA report, it is estimated that the U.S. will exhibit significant market growth due to growing meat and poultry industry, increasing animal health expenditure.
Asia-Pacific is expected to register a steady revenue CAGR over the forecast period due to higher R&D activities, higher incidence of liver diseases, unmet medical needs and investments due to the region’s increasing healthcare industry.
North America is the fastest growing region in the market. They export poultry, poultry and various meat products. Increasing government support to raise awareness of the avian influenza virus and improve efficiency of the avian influenza vaccine is also having a positive impact on market growth. North America is expected to record the highest revenue share in the global market due to increasing R&D expenditure in the form of lucrative payment plans, pharmaceutical companies and R&D institutes is due to new medicines and important people in the region.
Global Avian Influenza Vaccine Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Avian Influenza Vaccine Market Dynamics
Drivers
Rise in Rate of Diseases
- Avian influenza can be defined as a disease caused by avian influenza virus type-A. This virus is commonly found in waterfowl and can infect domestic chickens and other bird species. Based on viral surface proteins, subtypes of influenza type A viruses can be classified into neuraminidase (NA) and hemagglutinin (HA). Based on their molecular characteristics and ability to cause disease and death in chicken avian influenza viruses are classified as highly pathogenic and low pathogenicity but both in poultry, high prevalence is reported. Nonpathogenic bird flu viruses show no signs of illness. Only mild diseases such as egg decline and wildflies show it. However, infection with the highly pathogenic influenza virus is associated with high mortality.
Growing Incidence of Poultry Mortality
- Increasing incidence of disease, especially in developing regions, is a major cause of mortality in more than 90% of poultry farms. High demand for poultry vaccines, ongoing research to develop effective vaccines, and rising incidence of infectious diseases contribute to the global influenza vaccines market but these vaccines rapid deterioration at room temperature in two hours makes it unsuitable for transport to remote villages. Furthermore, according to the U.S. According to the Department of Agriculture (U.S. DA), currently available vaccines do not meet efficacy requirements and therefore, should not be used to treat avian influenza outbreaks.
Restraints
Viral Mutational Challenges
- The rapid mutation rate of avian influenza virus presents a challenge to maintain vaccine coverage. There are ongoing research opportunities to understand the dynamics of the virus and to improve the quality of vaccines accordingly.
Global Distribution Challenges
- Global avian influenza vaccination, especially in poultry-rich areas, remains a challenge. There are also opportunities for collaboration in the distribution system to overcome access barriers.
Health Approach
- Development opportunities are based on a single approach to health that considers the links between human, animal and environmental health. This holistic approach is necessary to manage the complexity of avian influenza.
Request Free Customization of this report to help us to meet your business objectives.
Avian Influenza Vaccine Market Competitive Landscape
The competitive environment of the Global Avian Influenza Vaccine Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.
Top Player’s Company Profiles
- Boehringer Ingelheim International GmbH (Germany)
- Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)
- Ceva (US)
- Yebio Bioengineering Co., Ltd (China)
- Zoetis (US)
- FATRO S.P.A. (Italy)
- CAVAC (South Korea)
- Tianjin Ringpu Bio-Technology Co., Ltd (China)
- PT Japfa Comfeed Indonesia Tbk (Indonesia)
- Chengdu Tech-bank Biological Products Co., Ltd (China)
- Merck Animal Health (US)
- Medion (Indonesia)
- Avimex Animal Health (Mexico)
- JOVAC (Jordan)
- QYH BIOTECH COMPANY LIMITED (China)
Recent Developments
- February 2023: The United States Department of Agriculture (USDA) provides a $10 million grant program to support research and development of improved bird flu vaccines for poultry farms This program aims to develop a next generation vaccine protect against various strains of influenza.
- February 2023: Service Animal Health is releasing its CEVA FLU H5/H7 vaccine, a new recombinant adenovirus vector vaccine for poultry that provides comprehensive coverage against different influenza A subtypes.
- February 2023: A Chinese research group is publishing a successful DNA vaccine trial for chickens, which could pave the way for a more stable and scalable vaccine.
Avian Influenza Vaccine Key Market Trends
- Along with Israel, China, India and South Korea have the highest number of bird flu viruses in Asia-Pacific. This is followed by rapid supply chain improvements and a growing R&D infrastructure through supportive government policies.
- According to the U.S. developed the first COVID-19 vaccine, secured its position as the fastest growing market for avian influenza to factors such as increased awareness of animal welfare across the continent and activities related to veterinary and veterinary research.
- The rapid spread of avian influenza in already vaccinated populations such as India has led to antigenic and genetic changes in the structure of the virus.
Avian Influenza Vaccine Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. Most A(H5) viruses found in wild birds and poultry are LPAIs, however, HPAI A(H5) viruses have also been identified. Sporadic human infections with the A(H5) virus have been reported, such as HPAI A(H5N1) virus associated with poultry diseases in countries around the world for example, in March 2022, avian influenza A(H5N1). virus (H5N1 avian influenza) highly pathogenic virus) were detected in wild birds in the US in 14 states Increased government programs are expected to raise awareness among farmers about avian influenza, private funding to produce poultry rise in efficacy of flu vaccines and rise in poultry production will contribute to the growth of the market.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 140.0 Billion |
| Market size value in 2031 | USD 202.74 Billion |
| Growth Rate | 4.2% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Avian Influenza Vaccine Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Avian Influenza Vaccine Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Avian Influenza Vaccine Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Avian Influenza Vaccine Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Avian Influenza Vaccine Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Avian Influenza Vaccine Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
